HbA1c monitoring interval in patients on treatment for stable Type 2 diabetes. A ten-year retrospective, open cohort study
Diabetes Research and Clinical Practice Nov 22, 2017
Ohde S, et al. - In this study, experts sought to determine an informative interval for HbA1c in DM patients with stable glycemic control, based on test characteristics of the HbA1C assay using the signal-to-noise ratio method.
An informative interval for HbA1c monitoring was conducted once every year when patients achieved stable glycemic control at their HbA1c goal. Current guidelines could contribute to substantial over-testing, which suggested testing every 6 months.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries